Aveo Pharmaceuticals asserts that a stop-production notice was issued due to non-compliance with GMP standards, not for exporting opioid-based drugs. They have taken corrective measures and are working with authorities, aiming to resume operations soon, as many livelihoods depend on it.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5FvT3o8
via IFTTT
No comments:
Post a Comment